Berenberg Bank Reaffirms “Buy” Rating for Smith & Nephew (LON:SN)

Berenberg Bank reiterated their buy rating on shares of Smith & Nephew (LON:SN) in a report released on Thursday morning, Marketbeat Ratings reports. The brokerage currently has a GBX 1,450 ($18.21) target price on the stock.

Several other brokerages also recently commented on SN. Royal Bank of Canada reaffirmed an outperform rating and set a GBX 1,500 ($18.84) price objective on shares of Smith & Nephew in a research note on Friday, April 5th. Barclays reaffirmed an equal weight rating and set a GBX 1,150 ($14.45) price target on shares of Smith & Nephew in a research report on Friday, February 9th. Finally, JPMorgan Chase & Co. reiterated an overweight rating and issued a GBX 1,300 ($16.33) price objective on shares of Smith & Nephew in a research report on Thursday, April 18th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of Moderate Buy and an average price target of GBX 1,346.20 ($16.91).

Smith & Nephew Trading Up 0.9 %

LON:SN traded up GBX 9 ($0.11) during midday trading on Thursday, reaching GBX 985.60 ($12.38). 2,907,511 shares of the stock traded hands, compared to its average volume of 343,671. The stock has a market capitalization of £8.62 billion, a P/E ratio of 4,106.67, a PEG ratio of 0.46 and a beta of 0.51. The company has a debt-to-equity ratio of 59.11, a quick ratio of 0.84 and a current ratio of 1.77. The company has a fifty day moving average of GBX 1,021.40 and a 200 day moving average of GBX 1,034.26. Smith & Nephew has a 12 month low of GBX 887 ($11.14) and a 12 month high of GBX 1,316.75 ($16.54).

Smith & Nephew Increases Dividend

The business also recently declared a dividend, which will be paid on Wednesday, May 22nd. Investors of record on Thursday, March 28th will be paid a $0.23 dividend. This is an increase from Smith & Nephew’s previous dividend of $0.14. This represents a yield of 1.62%. The ex-dividend date of this dividend is Thursday, March 28th. Smith & Nephew’s dividend payout ratio is presently 12,500.00%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.